Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors - experience of the EU-RHAB registry.
Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S, Timmermann B, Kortmann RD, Koscielniak E, Schneppenheim R, Warmuth-Metz M, Gerß J, Siebert R, Graf N, Boos J, Frühwald MC. Seeringer A, et al. Klin Padiatr. 2014 May;226(3):143-8. doi: 10.1055/s-0034-1368719. Epub 2014 Mar 14. Klin Padiatr. 2014. PMID: 24633978
Clinical and genetic features of rhabdoid tumors of the heart registered with the European Rhabdoid Registry (EU-RHAB).
Bartelheim K, Sumerauer D, Behrends U, Kodetova D, Kucera F, Leuschner I, Neumayer P, Oyen F, Rübe C, Siebert R, Schneppenheim R, Seeringer A, Vasovcak P, Frühwald MC. Bartelheim K, et al. Among authors: seeringer a. Cancer Genet. 2014 Sep;207(9):379-83. doi: 10.1016/j.cancergen.2014.04.005. Epub 2014 Apr 21. Cancer Genet. 2014. PMID: 24972932
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.
Bartelheim K, Nemes K, Seeringer A, Kerl K, Buechner J, Boos J, Graf N, Dürken M, Gerss J, Hasselblatt M, Kortmann RD, Teichert von Luettichau I, Nagel I, Nygaard R, Oyen F, Quiroga E, Schlegel PG, Schmid I, Schneppenheim R, Siebert R, Solano-Paez P, Timmermann B, Warmuth-Metz M, Frühwald MC. Bartelheim K, et al. Among authors: seeringer a. Cancer Med. 2016 Aug;5(8):1765-75. doi: 10.1002/cam4.741. Epub 2016 May 26. Cancer Med. 2016. PMID: 27228363 Free PMC article.
Protocol for minimizing the risk of metachronous adenomas of the colorectum with green tea extract (MIRACLE): a randomised controlled trial of green tea extract versus placebo for nutriprevention of metachronous colon adenomas in the elderly population.
Stingl JC, Ettrich T, Muche R, Wiedom M, Brockmöller J, Seeringer A, Seufferlein T. Stingl JC, et al. Among authors: seeringer a. BMC Cancer. 2011 Aug 18;11:360. doi: 10.1186/1471-2407-11-360. BMC Cancer. 2011. PMID: 21851602 Free PMC article. Clinical Trial.
Pharmacogenetic predictors for EGFR-inhibitor-associated skin toxicity.
Parmar S, Schumann C, Rüdiger S, Boeck S, Heinemann V, Kächele V, Seeringer A, Paul T, Seufferlein T, Stingl JC. Parmar S, et al. Among authors: seeringer a. Pharmacogenomics J. 2013 Apr;13(2):181-8. doi: 10.1038/tpj.2011.51. Epub 2011 Dec 13. Pharmacogenomics J. 2013. PMID: 22158333
26 results